Repligen Announces CEO Transition Plan Breaking News: $RGEN Repligen Announces CEO Transition PlanWALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that its Board of Directors (“Board”) has approved the planned transition of Tony J. Hunt from Chief Executiv...
RGEN - Repligen Announces CEO Transition Plan